GL1X · GenesisL1 explorer

Research workbench

Structure based optimization of JAK1-ATP binding pocket inhibitors in the aminopyrazole class

Analyse Structure based optimization of JAK1-ATP binding pocket inhibitors in the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6RSH
Type
protein
Length
567 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK1
EC
2.7.10.2
UniProt
P23458
Ligands
KHE
Pockets
3 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK1 (EC 2.7.10.2)protein28642% helix, 20% strandP23458
BTyrosine-protein kinase JAK1 (EC 2.7.10.2)protein28142% helix, 21% strandP23458

Ligands and binding sites

  • KHE · 1-[(3~{R},4~{R})-4-(cyanomethyl)-3-fluoranyl-1-[(4-phenylphenyl)methyl]piperidin-4-yl]-3-(cyclopropylcarbonylamino)pyrazole-4-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16730.750.8154KHE
26940.720.7965KHE
3580.500.8612empty

Interfaces

1 interface between chains.

  • A–B · 940 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 6RSH · Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.